Evidence map›Paper›PMID 19802337›Full record

ArticleCurrent opinion in colloid & interface science2008

AFM of biological complexes: what can we learn?

Maria Gaczynska, Pawel A Osmulski

Open access · greenAbstract read
In one paragraph

Article in Current opinion in colloid & interface science, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 56 citations in OpenAlex.

  1. Nanobio Interface Between Proteins and 2D Nanomaterials.ACS applied materials & interfaces · 2023
    Review
  2. Article
  3. Localizing Binding Sites on Bioconjugated Hydrogen-Bonded Organic Semiconductors at the Nanoscale.Chemphyschem : a European journal of chemical physics and physical chemistry · 2020
    Article
  4. Article
  5. Review
  6. Biophysical Tools to Study Cellular Mechanotransduction.Bioengineering (Basel, Switzerland) · 2017
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. AFM force measurements of the gp120-sCD4 and gp120 or CD4 antigen-antibody interactions.Biochemical and biophysical research communications · 2011
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria GaczynskaDepartment of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX, 78245.
Pawel A Osmulski
The University of Texas Health Science Center at San Antonio · US

Funding

Mechanisms of Regulation of the Proteosome ActivitiesR01GM069819 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GACZYNSKA, MARIA E · 2004 to 2008
$1.1M
NIGMS NIH HHS R01 GM069819
6 · The paper itself

Abstract

The term "biological complexes" broadly encompasses particles as diverse as multisubunit enzymes, viral capsids, transport cages, molecular nets, ribosomes, nucleosomes, biological membrane components and amyloids. The complexes represent a broad range of stability and composition. Atomic force microscopy offers a wealth of structural and functional data about such assemblies. For this review, we choose to comment on the significance of AFM to study various aspects of biology of selected nonmembrane protein assemblies. Such particles are large enough to reveal many structural details under the AFM probe. Importantly, the specific advantages of the method allow for gathering dynamic information about their formation, stability or allosteric structural changes critical for their function. Some of them have already found their way to nanomedical or nanotechnological applications. Here we present examples of studies where the AFM provided pioneering information about the biology of complexes, and examples of studies where the simplicity of the method is used toward the development of potential diagnostic applications.

Identifiers

PMID19802337
PMCPMC2630216
OpenAlexW2068454239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.